%0 Journal Article
%T Editorial on ¡°The AvaALL Randomized Clinical Trial¡±
%A Alberto Pavan
%A Giulia Pasello
%A Laura Bonanno
%A Stefano Indraccolo
%J SCIE-indexed Journal
%D 2019
%R 10.21037/jtd.2019.02.62
%X Angiogenesis is essential for tumor growth and blood-borne metastasis, while pharmacological inhibition of tumor-induced angiogenesis is a strategy used in several solid tumors. In advanced non-squamous non-oncogene addicted non-small cell lung cancer (NSCLC), the use of bevacizumab¡ªa monoclonal antibody targeting vascular endothelial growth factor (VEGF)¡ªin addition to platinum-doublet is approved for first-line treatment (1,2)
%U http://jtd.amegroups.com/article/view/27417/html